Home/Pipeline/MSC‑Diabetes

MSC‑Diabetes

Type 1 Diabetes

Phase 1Active

Key Facts

Indication

Type 1 Diabetes

Phase

Phase 1

Status

Active

Company

About Advancells

India’s leading GMP‑compliant stem‑cell and exosome therapy provider for personalized regenerative medicine.

View full company profile

Therapeutic Areas

Regenerative Medicine Neurology Orthopedics Dermatology Reproductive Health Ophthalmology

Other Type 1 Diabetes Drugs

Drug	Company	Phase	Status
eRapa	Biodexa Pharmaceuticals	Preclinical	Research
ImmCelz™	Creative Medical Technology Holdings	Clinical Trial	Active
Adimune (ADi-001/002)	Aditxt	Preclinical / Early Clinical	Active
BioChaperone® Lispro (THDB0206)	Adocia	Phase 3	Active
AdoShell® Islet Cell Therapy	Adocia	Preclinical	Platform Development
Pediatric Indications (<2 years)	Tandem Diabetes	Research	Exploratory
Icovamenib (BMF-219)	Biomea Fusion	Phase 2	Completed Follow-up, Data Pending
Undisclosed Novel Strategy	CG Scientific	Pre-clinical	Early Research
Sotagliflozin	Lexicon Pharmaceuticals	Phase 3	Regulatory Path Uncertain
Stem Cell-Derived Beta Cells	BioTalentum	Pre-clinical	Active
NICHE	Continuity Biosciences	Pre-clinical	Active
Type I Diabetes	Genclis	Discovery	Active